Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nobelpharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7585
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseases; neurology, genetic disorders, women’s health and respiratory. NobelPharma conducts research and development of drugs under categories such as orphan drugs, off-label drug, medicines used for additional efficacy, and pediatric pharmaceuticals. The company operates its branch offices in Hokkaido-Tohoku, Kanshinetu, Tokyo, Minamikanto, Tokai-Hokuriku, Kansai, Chu-Shikoku, and Kyushu, Japan. NobelPharma is headquartered in Tokyo, Japan.

Nobelpharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Nobelpharma Enters into Co-Promotion with ASKA Pharma and Medipal 10
NobelPharma Enters into Agreement with TOKUHON 11
Licensing Agreements 12
NobelPharma Enters into Licensing Agreement with Osaka University 12
NobelPharma Enters into Licensing Agreement with Kitasato University 13
NobelPharma Enters into Licensing Agreement with Savara 14
NobelPharma Enters into Licensing Agreement with Kurume University 15
NobelPharma Enters into Licensing Agreement with Serendex Pharma 16
NobelPharma Enters into Licensing Agreement with Gifu University 17
NobelPharma Enters Into Licensing Agreement With Pfizer For Sirolimus 18
SRI International Enters into Licensing Agreement with Nobelpharma 19
Eisai To Enter Into Licensing Agreement With Nobelpharma For Antineoplastic Agent Gliadel 7.7Mg Implant 20
Nobelpharma Co Ltd – Key Competitors 21
Nobelpharma Co Ltd – Key Employees 22
Nobelpharma Co Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nobelpharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nobelpharma Enters into Co-Promotion with ASKA Pharma and Medipal 10
NobelPharma Enters into Agreement with TOKUHON 11
NobelPharma Enters into Licensing Agreement with Osaka University 12
NobelPharma Enters into Licensing Agreement with Kitasato University 13
NobelPharma Enters into Licensing Agreement with Savara 14
NobelPharma Enters into Licensing Agreement with Kurume University 15
NobelPharma Enters into Licensing Agreement with Serendex Pharma 16
NobelPharma Enters into Licensing Agreement with Gifu University 17
NobelPharma Enters Into Licensing Agreement With Pfizer For Sirolimus 18
SRI International Enters into Licensing Agreement with Nobelpharma 19
Eisai To Enter Into Licensing Agreement With Nobelpharma For Antineoplastic Agent Gliadel 7.7Mg Implant 20
Nobelpharma Co Ltd, Key Competitors 21
Nobelpharma Co Ltd, Key Employees 22
Nobelpharma Co Ltd, Other Locations 24

List of Figures
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nobelpharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Blue Dolphin Energy Co (BDCO):企業の財務・戦略的SWOT分析
    Summary Blue Dolphin Energy Co (Blue Dolphin) operates as an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolph …
  • Netcare Ltd (NTC):企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • Universal Robina Corp:企業の戦略・SWOT・財務情報
    Universal Robina Corp - Strategy, SWOT and Corporate Finance Report Summary Universal Robina Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Leukocare AG-医療機器分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Diagnostics For All Inc:企業の製品パイプライン分析
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Empire Resorts Inc:戦略・SWOT・企業財務分析
    Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vect-Horus SAS (Vect-Horus) is a biotechnology company that designs and develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into organs including the brain and tumors. The company combines molecules of interest to peptide-vectors that targets receptor mediate …
  • Harvard Medical School-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • A.P. Moller – Maersk AS (MAERSK B):石油・ガス:M&Aディール及び事業提携情報
    Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry cargo, refrigerated cargo, special cargo and also conducts used container sales and supports intermo …
  • IDG Communications Inc:企業の戦略的SWOT分析
    IDG Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a biopharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (B …
  • Graham Packaging Company, L.P.:企業の戦略・SWOT・財務情報
    Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report Summary Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ebix Inc:企業のM&A・事業提携・投資動向
    Ebix Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ebix Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company provides product such as xpresys lung that helps physicians to diagnose complex diseases with a non-invasive blood test. …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilize …
  • Ultradent Products Inc:企業の戦略的SWOT分析
    Ultradent Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Paladin Energy Ltd (PDN)
    Paladin Energy Ltd (PDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆